As shown in Figure 5D, most immune cells were significantly enriched in CRC patients in cluster-2, such as CD8+ T cells, Tregs, resting NK cells, tumor-associated macrophages (TAMs), and resting mast cells. Here, CD8A is linked to colorectal carcinoma.